Ravishankar Jayadevappa1, Sumedha Chhatre, Jerry C Johnson, S Bruce Malkowicz. 1. Department of Medicine, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania; Leonard Davis Institute of Health Economics, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania. jravi@mail.med.upenn.edu.
Abstract
BACKGROUND: The objective of this study was to assess the racial and ethnic disparities in outcomes and their association with process-of-care measures for elderly Medicare recipients with localized prostate cancer. METHODS: The Surveillance, Epidemiology, and End Results-Medicare databases for the period from 1995 to 2003 were used to identify African-American men, non-Hispanic white men, and Hispanic men with localized prostate cancer, and data were obtained for the 1-year period before the diagnosis of prostate cancer and up to 8 years postdiagnosis. The short-term outcomes of interest were complications, emergency room visits, readmissions, and mortality; the long-term outcomes of interest were prostate cancer-specific mortality and all-cause mortality; and process-of-care measures of interest were treatment and time to treatment. Cox proportional hazards regression, logistic regression, and Poisson regression were used to study the racial and ethnic disparities in outcomes and their association with process-of-care measures. RESULTS: Compared with non-Hispanic white patients, African-American patients (Hazard ration [HR], 1.43; 95% confidence interval [CE], 1.19-1.86) and Hispanic patients (HR=1.39; 95% CI, 1.03-1.84) had greater hazard of long term prostate specific mortality. African-American patients also had greater odds of emergency room visits (odds ratio, 1.4; 95% CI, 1.2-1.7) and greater all-cause mortality (HR, 1.39; 95% CI, 1.3-1.5) compared with white patients. The time to treatment was longer for African-American patients and was indicative of a greater hazard of all-cause, long-term mortality. Hispanic patients who underwent surgery or received radiation had a greater hazard of long-term prostate-specific mortality compared with white patients who received hormone therapy. CONCLUSIONS: Racial and ethnic disparities in outcomes were associated with process-of-care measures (the type and time to treatment). The current results indicated that there is an opportunity to reduce these disparities by addressing these process-of-care measures.
BACKGROUND: The objective of this study was to assess the racial and ethnic disparities in outcomes and their association with process-of-care measures for elderly Medicare recipients with localized prostate cancer. METHODS: The Surveillance, Epidemiology, and End Results-Medicare databases for the period from 1995 to 2003 were used to identify African-American men, non-Hispanic white men, and Hispanic men with localized prostate cancer, and data were obtained for the 1-year period before the diagnosis of prostate cancer and up to 8 years postdiagnosis. The short-term outcomes of interest were complications, emergency room visits, readmissions, and mortality; the long-term outcomes of interest were prostate cancer-specific mortality and all-cause mortality; and process-of-care measures of interest were treatment and time to treatment. Cox proportional hazards regression, logistic regression, and Poisson regression were used to study the racial and ethnic disparities in outcomes and their association with process-of-care measures. RESULTS: Compared with non-Hispanic white patients, African-American patients (Hazard ration [HR], 1.43; 95% confidence interval [CE], 1.19-1.86) and Hispanic patients (HR=1.39; 95% CI, 1.03-1.84) had greater hazard of long term prostate specific mortality. African-American patients also had greater odds of emergency room visits (odds ratio, 1.4; 95% CI, 1.2-1.7) and greater all-cause mortality (HR, 1.39; 95% CI, 1.3-1.5) compared with white patients. The time to treatment was longer for African-American patients and was indicative of a greater hazard of all-cause, long-term mortality. Hispanic patients who underwent surgery or received radiation had a greater hazard of long-term prostate-specific mortality compared with white patients who received hormone therapy. CONCLUSIONS: Racial and ethnic disparities in outcomes were associated with process-of-care measures (the type and time to treatment). The current results indicated that there is an opportunity to reduce these disparities by addressing these process-of-care measures.
Authors: Vickie L Shavers; Martin L Brown; Arnold L Potosky; Carrie N Klabunde; W W Davis; Judd W Moul; Angela Fahey Journal: J Gen Intern Med Date: 2004-02 Impact factor: 5.128
Authors: David C Miller; Mark S Litwin; Martin G Sanda; James E Montie; Rodney L Dunn; Jennifer Resh; Howard Sandler; John T Wei Journal: Cancer Date: 2003-03-15 Impact factor: 6.860
Authors: Arnold L Potosky; Joan L Warren; Elyn R Riedel; Carrie N Klabunde; Craig C Earle; Colin B Begg Journal: Med Care Date: 2002-08 Impact factor: 2.983
Authors: Beth A Virnig; Joan L Warren; Gregory S Cooper; Carrie N Klabunde; Nicola Schussler; Jean Freeman Journal: Med Care Date: 2002-08 Impact factor: 2.983
Authors: Paul A Godley; Anna P Schenck; M Ahinee Amamoo; Victor J Schoenbach; Sharon Peacock; Michelle Manning; Michael Symons; James A Talcott Journal: J Natl Cancer Inst Date: 2003-11-19 Impact factor: 13.506
Authors: Rebecca S Lash; Janice F Bell; Sarah C Reed; Hermine Poghosyan; James Rodgers; Katherine K Kim; Richard J Bold; Jill G Joseph Journal: Cancer Nurs Date: 2017 Mar/Apr Impact factor: 2.592
Authors: Márton Koch; Csaba Varga; Viktor Soós; Lilla Prenek; Lili Porcsa; Alíz Szakáll; Gergely Bilics; Balázs Hunka; Szabolcs Bellyei; János Girán; István Kiss; Éva Pozsgai Journal: BMC Emerg Med Date: 2022-06-23
Authors: Marianne Schmid; Christian P Meyer; Gally Reznor; Toni K Choueiri; Julian Hanske; Jesse D Sammon; Firas Abdollah; Felix K H Chun; Adam S Kibel; Reginald D Tucker-Seeley; Philip W Kantoff; Stuart R Lipsitz; Mani Menon; Paul L Nguyen; Quoc-Dien Trinh Journal: JAMA Oncol Date: 2016-01 Impact factor: 31.777
Authors: Jennifer Cullen; Stephen A Brassell; Yongmei Chen; Christopher Porter; James L'esperance; Timothy Brand; David G McLeod Journal: Prostate Cancer Date: 2011-06-26
Authors: Sue M Evans; Jeremy L Millar; Caroline M Moore; John D Lewis; Hartwig Huland; Fanny Sampurno; Sarah E Connor; Paul Villanti; Mark S Litwin Journal: BMJ Open Date: 2017-11-28 Impact factor: 2.692
Authors: Nynikka R Palmer; Janet K Shim; Celia P Kaplan; Dean Schillinger; Sarah D Blaschko; Benjamin N Breyer; Rena J Pasick Journal: BMJ Open Date: 2020-08-05 Impact factor: 2.692